youtube_live
Q3 2026 earnings • released • EPS beat +6.08% • Revenue miss -2.06%
See resultschevron_right
ILMN:NASDAQ
Illumina Inc
$226.58
arrow_downward
-3.99%(-9.41) 1D
$226.58
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ILMN...
Open
$236.01
High
$236.01
Low
$223.33
Mkt. cap
34.21B
Avg. vol.
2.65M
Volume
2.93M
P/E ratio
38.83
52-wk high
$309.34
52-wk low
$112.65
EPS
$5.83
Beta
1.41
Shares outstanding
151.00M
No. of employees
9K
Open
$236.01
High
$236.01
Low
$223.33
Mkt. cap
34.21B
Avg. vol.
2.65M
Volume
2.93M
P/E ratio
38.83
52-wk high
$309.34
52-wk low
$112.65
EPS
$5.83
Beta
1.41
Shares outstanding
151.00M
No. of employees
9K
News stories
From web sources and news partners
GuruFocus
·
2 hours ago
Illumina (ILMN) Selected for Singapore's SG-INSIGHT Whole-Genome Sequencing Initiative
Yahoo Finance
·
3 hours ago
Illumina selected to help bring precision medicine into everyday healthcare in Singapore
TradingView
·
3 hours ago
Illumina, Inc. (ILMN) Selected for Singapore Study of Around 450,000 People
Zacks
·
4 hours ago
3 Stocks to Watch Following Guidance Upgrades
Profile
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
About Illumina Inc
CEOJacob Thaysen
Employees8.62K
Founded1998
HeadquartersSan Diego, California, United States
SectorHealth care
Websiteillumina.com